On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
April 15, 2018
The Quarterly Performance Report for the first quarter of the 2017-2018 fiscal year is now available online. Continue reading
March 30, 2018
Click here for more information on authorization for pharmacists to administer meningococcal and shingles vaccines under certain circumstances. Continue reading